Promising cancer approach reported


Cancer. It’s a word nobody wants to hear. The many forms and deadly results it causes brings major losses and hardships to families around the world. Billions of dollars have been donated to cancer research, yet cures have not been found.

Advancements in technology and medicine have slowed the progress of tumors; and radiation and chemotherapy have cured patients; however, there isn’t a treatment that can 100 percent cure cancer every single time.

A recent research at Stanford University in California found impressive results pertaining to curing cancer in mice. The research project consisted of 90 mice whom were injected with two immune-stimulating agents directly into the tumors.

Lead researcher Ronald Levy and Idit Sagiv-Barfi pioneered the project and cured 87 of the 90 mice injected with the medicine. All 87 of the mice cured had complete obliteration of the tumors and were entirely cancer free.

One of the two agents is currently approved for human use, but the other agent is not.

According to a recent interview conducted by the Stanford medical team, Levy believes the breakthrough starts with boosting the immune system.

“When we use these two agents together, we see the elimination of tumors all over the body,” said Ronald Levy, MD, professor of oncology.

“This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.”

The types of cancers the mice were sick with were leukemia, lymphoma, breast cancer, and melanoma. The trick to killing the cancer was activating the T-Cells in tumors, which would effectively destroy the tumors from the inside out.

The impressive results have yet to be tested on humans. The two immune-stimulating agents are currently waiting to be reviewed by the FDA.